COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1352: Articles 13511-13520  | Next

Influenza infection, Acute myocardial Infarction, Flu Shot during COVID-19 Pandemic in US population. A Review of Literature.
Baral, N., Nayak, N.
10.1101/2021.07.14.21260549 — Posted: 2021-07-16
Visualizing Amino Acid Substitutions in a Physicochemical Vector Space
Nemzer, L. R.
10.1101/2021.07.15.452549 — Posted: 2021-07-16
Quantifying within-school SARS-CoV-2 transmission and the impact of lateral flow testing in secondary schools in England
Leng, T., Hill, E. M., Holmes, A., Southall, E., Thompson, R. N., Tildesley, M. J., Keeling, M. J., Dyson, L.
10.1101/2021.07.09.21260271 — Posted: 2021-07-16
SARS-CoV-2 variants of concern, Gamma (P.1) and Delta (B.1.617), sensitive detection and quantification in wastewater employing direct RT-qPCR
Yaniv, K., Ozer, E., Kushmaro, A.
10.1101/2021.07.14.21260495 — Posted: 2021-07-16
The Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland (Study protocol)
Baysson, H., Pennachio, F., Wisniak, A., Zabella, M. E., Collombet, P., Lorthe, E., Joost, S., Balavoine, J.-F., Bachmann, D., Azman, A., Pittet, D., Chappuis, F., Kherad, O., Kaiser, L., Guessous, I., Stringhini, S., Specchio COVID19 study group
10.1101/2021.07.14.21260489 — Posted: 2021-07-16
Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: active prospective surveillance, December 2020 to March 2021, England
Ladhani, S. N., Ireland, G., Baawuah, F., Beckmann, J., Okike, I. O., Ahmad, S., Garstang, J., Brent, A. J., Brent, B., Aiano, F., Amin-Chowdhury, Z., Kall, M., Borrow, R., Linley, E., Zambon, M., Poh, J., Warrener, L., Lackenby, A., Ellis, J., Amirthalingam, G., Brown, K. E., Ramsay, M. E.
10.1101/2021.07.14.21260496 — Posted: 2021-07-16
SARS-CoV-2 Antibody Lateral Flow Assay for antibody prevalence studies following vaccine roll out: a Diagnostic Accuracy Study
Cann, A. H. C., Clarke, C. L., Brown, J. C., Thomson, T., Prendecki, M., Moshe, M., Badhan, A., Elliott, P., Darzi, A., Riley, S., Ashby, D., Willicombe, M., Kelleher, P., Randell, P., Ward, H., Barclay, W., Cooke, G.
10.1101/2021.07.14.21260488 — Posted: 2021-07-16
Intestinal organoids expose heterogeneity in SARS-CoV-2 susceptibility
Jang, K. K., Kaczmarek, M. E., Dallari, S., Chen, Y.-H., Axelrad, J., Stapleford, K. A., Cadwell, K.
10.1101/2021.07.16.452680 — Posted: 2021-07-16
Neutralization of recombinant RBD-subunit vaccine ZF2001-elicited antisera to SARS-CoV-2 variants including Delta
Zhao, X., Zheng, A., Li, D., Zhang, R., Sun, H., Wang, Q., Gao, G. F., Han, P., Dai, L.
10.1101/2021.07.15.452504 — Posted: 2021-07-16
A single de novo substitution in SARS-CoV-2 spike informs enhanced adherence to human ACE2.
Erausquin, E., Lopez-Sagaseta, J.
10.1101/2021.07.16.452441 — Posted: 2021-07-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).